Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,3987788,peak plasma concentration,After oral dosing the mean peak plasma concentration was 116 ng/ml and mean bioavailability was 75%.,Pharmacokinetics and Pharmacodynamics of procyclidine in man. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3987788/),[ng] / [ml],116,102479,DB00387,Procyclidine
,3987788,bioavailability,After oral dosing the mean peak plasma concentration was 116 ng/ml and mean bioavailability was 75%.,Pharmacokinetics and Pharmacodynamics of procyclidine in man. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3987788/),%,75,102480,DB00387,Procyclidine
,3987788,volume of distribution,"After both oral and intravenous dosing the mean values for the volume of distribution, total body clearance and plasma elimination half-life of procyclidine were in the order of 1 l/kg, 68 ml/min and 12 h respectively.",Pharmacokinetics and Pharmacodynamics of procyclidine in man. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3987788/),[l] / [kg],1,102481,DB00387,Procyclidine
,3987788,total body clearance,"After both oral and intravenous dosing the mean values for the volume of distribution, total body clearance and plasma elimination half-life of procyclidine were in the order of 1 l/kg, 68 ml/min and 12 h respectively.",Pharmacokinetics and Pharmacodynamics of procyclidine in man. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/3987788/),[ml] / [min],68,102482,DB00387,Procyclidine
,3987788,plasma elimination half-life,"After both oral and intravenous dosing the mean values for the volume of distribution, total body clearance and plasma elimination half-life of procyclidine were in the order of 1 l/kg, 68 ml/min and 12 h respectively.",Pharmacokinetics and Pharmacodynamics of procyclidine in man. ,"t1/2,Î²-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/3987788/),h,12,102483,DB00387,Procyclidine
,11440081,nasal bioavailability,"The nasal bioavailability of procyclidine in rats and dogs, based on the radioactivity, was calculated to be 81.1 and 98.6%, respectively.",Nasal absorption of procyclidine in rats and dogs. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11440081/),%,81.1,136406,DB00387,Procyclidine
,11440081,nasal bioavailability,"The nasal bioavailability of procyclidine in rats and dogs, based on the radioactivity, was calculated to be 81.1 and 98.6%, respectively.",Nasal absorption of procyclidine in rats and dogs. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11440081/),%,98.6,136407,DB00387,Procyclidine
